CD24 BINDING PROTEIN AND USE THEREOF - ACROIMMUNE BIOPHARMA CO LTD

Title:

CD24 BINDING PROTEIN AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2024/093882

Kind Code:

A1

Abstract:

Provided are a group CD24 binding proteins and uses thereof. Specifically provided is a group of antigen binding proteins, wherein cells expressing the antigen binding protein can have cytotoxicity and safety. Also provided is a use of the antigen binding protein in the preparation of a medication.

Inventors:

TONG DAN (CN)
LIU YANG (CN)

Application Number:

PCT/CN2023/127598

Publication Date:

May 10, 2024

Filing Date:

October 30, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ACROIMMUNE BIOPHARMA CO LTD (CN)
ACROIMMUNE BIOTECH CO LTD (CN)

International Classes:

C07K19/00; A61K35/17; A61P35/00; C12N5/10; C12N15/13; C12N15/62

Domestic Patent References:

WO2019111250A1

2019-06-13

Foreign References:

CN112424441A	2021-02-26
CN108373504A	2018-08-07
CN103819561A	2014-05-28
CN112725283A	2021-04-30

Attorney, Agent or Firm:

SHANGHAI DIANSHI PARTNERS, P.C. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD AND APPARATUS IN COMMUNICATION NODE USED FOR WIRELESS COMMUNICATION

Next Patent: METHOD AND DEVICE FOR NODE USED FOR WIRELESS COMMUNICATION